By BY KATIE THOMAS from NYT Health Critics said the company was profiteering from the coronavirus pandemic by seeking tax and monopoly benefits under a program intended to encourage drug development for rare diseases. https://ift.tt/2xli8yT
25 Mart 2020 Çarşamba
Gilead Withdraws Request for Special Orphan Status on Experimental Virus Treatment
By BY KATIE THOMAS from NYT Health Critics said the company was profiteering from the coronavirus pandemic by seeking tax and monopoly benefits under a program intended to encourage drug development for rare diseases. https://ift.tt/2xli8yT
Kaydol:
Kayıt Yorumları (Atom)
Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic
By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...
-
By BY EMILY ANTHES from NYT Health The F.D.A. authorized a breath-based test made by a small Texas company, which said it hoped that mobile...
-
By BY CARL ZIMMER from NYT Health https://ift.tt/2IHUMZY
-
https://ift.tt/2qR64Cz
Hiç yorum yok:
Yorum Gönder